Spatial differences and temporal changes in illicit drug use in E urope quantified by wastewater analysis C Ort, ALN van Nuijs, JD Berset, L Bijlsma, S Castiglioni, A Covaci, ... Addiction 109 (8), 1338-1352, 2014 | 423 | 2014 |
Spatio‐temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring I González‐Mariño, JA Baz‐Lomba, NA Alygizakis, MJ Andrés‐Costa, ... Addiction 115 (1), 109-120, 2020 | 190 | 2020 |
Estimation of illicit drugs consumption by wastewater analysis in Paris area (France) S Karolak, T Nefau, E Bailly, A Solgadi, Y Levi Forensic science international 200 (1-3), 153-160, 2010 | 162 | 2010 |
Presence of illicit drugs and metabolites in influents and effluents of 25 sewage water treatment plants and map of drug consumption in France T Nefau, S Karolak, L Castillo, V Boireau, Y Levi Science of the Total Environment 461, 712-722, 2013 | 146 | 2013 |
Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price TM Brunt, AM Atkinson, T Nefau, M Martinez, E Lahaie, A Malzcewski, ... International Journal of Drug Policy 44, 105-114, 2017 | 54 | 2017 |
The removal of illicit drugs and morphine in two waste water treatment plants (WWTPs) under tropical conditions DA Devault, T Néfau, Y Levi, S Karolak Environmental Science and Pollution Research 24, 25645-25655, 2017 | 39 | 2017 |
Drug analysis of residual content of used syringes: a new approach for improving knowledge of injected drugs and drug user practices T Néfau, E Charpentier, N Elyasmino, C Duplessy-Garson, Y Levi, ... International Journal of Drug Policy 26 (4), 412-419, 2015 | 38 | 2015 |
Hepatitis C transmission in injection drug users: could swabs be the main culprit? V Thibault, JL Bara, T Nefau, C Duplessy-Garson The Journal of infectious diseases 204 (12), 1839-1842, 2011 | 32 | 2011 |
CHEMSEX, NPS & risk reduction management: Preliminary results of a pilot study M Marillier, A Batisse, C Richeval, V Labrouve, M Martinez, D Allorge, ... Toxicologie Analytique et Clinique 29 (1), 47-56, 2017 | 28 | 2017 |
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE) TM Brunt, E Lefrançois, T Gunnar, A Arponen, T Seyler, AE Goudriaan, ... International Journal of Drug Policy 95, 103130, 2021 | 20 | 2021 |
Substances psychoactives en France: tendances récentes (2014-2015) A Cadet-Taïrou, M Gandilhon, M Martinez, T Néfau Tendances 105, 2015 | 17 | 2015 |
Substances psychoactives, usagers et marchés: les tendances récentes (2016-2017) A Cadet-Taïrou, M Gandilhon, M Martinez, M Milhet, T Néfau Tendances 121, 1-8, 2017 | 15 | 2017 |
Substances psychoactives, usagers et marchés: les tendances récentes (2015-2016) A Cadet-Taïrou, M Gandilhon, M Martinez, T Néfau, M Milhet Tendances 115, 8, 2016 | 14 | 2016 |
Substances illicites ou détournées: les tendances récentes (2013-2014) A Cadet-Taïrou, M Gandilhon, M Martinez, T Néfau Tendances 96 (6), 2014 | 14 | 2014 |
Nouveaux produits de synthèse. Dix ans de recul sur la situation française. Tendances n° 127 M Martinez, T Néfau, A Cadet-Taïrou | 13 | 2018 |
Theory versus practice, bacteriological efficiency versus personal habits: a bacteriological and user acceptability evaluation of filtering tools for people who inject drugs M Jauffret‐Roustide, A Chollet, A Santos, T Benoit, S Péchiné, ... Drug and Alcohol Review 37 (1), 106-115, 2018 | 12 | 2018 |
Nouveaux produits de synthèse identifiés en France depuis 2000 T Néfau, M Martinez Note d’information SINTES, 2014 | 11 | 2014 |
HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service M Torres-Leguizamon, EG Reynaud, T Néfau, C Duplessy Harm reduction journal 17, 1-13, 2020 | 10 | 2020 |
Chemsex, slam M Milhet, T Néfau, L Bordeaux, P Marseille Renouvellement des usages de drogues en contextes sexuels parmi les HSH …, 2017 | 10 | 2017 |
The comeback of Ecstasy: New designs and increased MDMA content C Richeval, L Humbert, T Nefau, M Martinez, D Allorge, JM Gaulier Toxicologie Analytique et Clinique 29 (1), 144-145, 2017 | 8 | 2017 |